NCT02376998

Brief Summary

Most blunt aortic injuries occur in the proximal proximal descending aorta causing acute transection of this vessel. Generally, surgical repair of the ruptured segment of aorta is associated with high rates of morbidity and mortality and in this view endovascular treatment seems to be a valid and safer alternative. Aim of this study is to review the experience of a single center with endovascular approach for the treatment of acute traumatic rupture of descending thoracic aorta

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2002

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2002

Completed
12 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 12, 2015

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 3, 2015

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

October 7, 2016

Completed
Last Updated

October 7, 2016

Status Verified

August 1, 2016

Enrollment Period

12 years

First QC Date

February 12, 2015

Results QC Date

May 24, 2016

Last Update Submit

August 15, 2016

Conditions

Keywords

Thoracic AortaTraumaEndovascular

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Major Adverse Events

    Evaluation of mortality, renal failure, cerebrovascular accident.

    from hospital discharge to 1 month after the procedure

Study Arms (1)

Valiant™ endoluminal procedure

EXPERIMENTAL

Data from early and long term complications following endoluminal stent-graft placement for thoracic endovascular aortic repair (TEVAR) procedure (Valiant™ endoluminal procedure) will be collected.

Device: Valiant™ endoluminal procedure

Interventions

Thoracic endovascular aortic repair with Endoluminal stent-graft placement (Valiant™ endoluminal stent-graft systems (Medtronic Inc., Santa Rosa, CA, USA) will be performed as follows: The diameter of the stent graft will be calculated from the largest diameter of the proximal/distal neck with an oversizing factor of 10-20%. The procedures will be done with local or general anaesthesia in case of unstable pre-operative hemodynamic conditions. After the procedure will be completed, a digital subtraction angiography and echocardiography with color-flow mapping were performed to verify the correct positioning of the stent and to detect any primary endoleak.

Valiant™ endoluminal procedure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with a diagnosis of acute transection of thoracic aorta;
  • a time frame range from trauma of 1-10 hours.

You may not qualify if:

  • Patients who do not fall into the above categories

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Serra R, de Franciscis S, Grande R, Butrico L, Perri P, Indolfi C, Mastroroberto P. Endovascular repair for acute traumatic transection of the descending thoracic aorta: experience of a single centre with a 12-years follow up. J Cardiothorac Surg. 2015 Nov 21;10:171. doi: 10.1186/s13019-015-0388-5.

MeSH Terms

Conditions

Wounds and Injuries

Results Point of Contact

Title
Prof. Raffaele Serra
Organization
University Magna Graecia of Catanzaro

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Raffaele Serra

Study Record Dates

First Submitted

February 12, 2015

First Posted

March 3, 2015

Study Start

November 1, 2002

Primary Completion

November 1, 2014

Study Completion

February 1, 2015

Last Updated

October 7, 2016

Results First Posted

October 7, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share